Literature DB >> 17191605

[Adverse drug reactions in a Suba hospital of Bogotá].

Sonia M Moscoso-Veloza1, Gloria F Ramírez-Cubillos, José J López-Gutierrez, Bárbara E Gerena-Useche.   

Abstract

OBJECTIVE: This study was carried out in order to identify, document and assess suspect of Adverse Drug Reactions (ADR) that are report to pharmacovigilance program of Suba Hospital.
METHODOLOGY: It was carried out an observational, descriptive and longitudinal study, in all the patients that consulted to the services of Urgencies and External Consultation, in the Hospital of Suba of the Bogotá city.
RESULTS: During the period of study 46 reports of suspicion of ADR were received, from those which 26 (56,6 %) corresponded to consultation reason, the 20 remaining it was indoor patient . In the classification for Organ-System, the gastrointestinal system presents the highest percentage of reports (30,4 %), followed by the cardiovascular (17,4 %), nervous central system (13 %), Skin (13 %), Obstetric (10,9 %), renal system (4,3 %). The therapeutic Groups with more reported percentages of suspicion of ADR were Antipsychotic (30,4 %), Nutritional Supplements (17,4 %), Anti-infective (10,9 %), the other pharmacological groups present similar or inferior percentages to those mentioned previously. The incidence of ADR as consultation reason was 3 ADR consultation reason/10,000 consultations / month.
CONCLUSIONS: It was identify to pregnant, children and young people as a risk group to development an ADR. A low proportion it was clasificated as a serious and less than half as a possible according World Health Organization algoritm.

Entities:  

Mesh:

Year:  2006        PMID: 17191605     DOI: 10.1590/s0124-00642006000200009

Source DB:  PubMed          Journal:  Rev Salud Publica (Bogota)        ISSN: 0124-0064


  1 in total

1.  [Adverse reactions to drugs used for COVID-19 in five Latin American countriesReações adversas a medicamentos utilizados para a COVID-19 em cinco países da América Latina].

Authors:  Tatiana Orjuela-Rodríguez; Robin Rojas-Cortés; Verónica Vergara; Francisca Aldunate; Giset Jiménez; Ismary Alfonso Orta; Kelly Serrano; Giovanna Jiménez; Diana Marcela Gil González; Diego Gutiérrez; Francisco Bosco Cortez; José David González; Analía Porrás; José Luis Castro
Journal:  Rev Panam Salud Publica       Date:  2022-09-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.